Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 21, 2026

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
06:15

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.

Published on: June 14, 2015

Amniotic membrane patching promotes ischemic rat heart repair.

Anna Cargnoni1, Marco Di Marcello, Marino Campagnol

  • 1Centro di Ricerca E. Menni, Fondazione Poliambulanza-Istituto Ospedaliero, 25124 Brescia, Italy.

Cell Transplantation
|August 5, 2009
PubMed
Summary

Applying human amniotic membrane to rat hearts after ischemia significantly improved cardiac function and preserved dimensions. This regenerative medicine approach shows potential for treating cardiac injury without cell engraftment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial VEGFR-2 Activation Precedes Severe Mucosal Injury in TNBS-Induced Colitis.

International journal of molecular sciences·2026
Same author

Mesenchymal stromal cells and neuroinflammation: a multimodal approach to neuroprotection and future therapeutic horizons.

Translational neurodegeneration·2026
Same author

A cell line-derived, immune-competent neurospheroid model to study neuroinflammation and human brain disorders.

Frontiers in immunology·2026
Same author

Beyond traditional models: microfluidic technologies for engineering the human placenta <i>in vitro</i>.

Frontiers in bioengineering and biotechnology·2026
Same author

Microinvasive, off-pump, transventricular neochordae implantation in recurrent mitral valve regurgitation after open heart surgical repair.

The Journal of thoracic and cardiovascular surgery·2026
Same author

RNA cargo profiling of muscle extracellular vesicles identifies candidate biomarkers of disease activity and muscle degeneration in FSHD.

Journal of translational medicine·2026

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Tissue Engineering

Background:

  • The amniotic membrane is utilized for wound healing and ophthalmological treatments, but its mechanisms are not fully understood.
  • Cells from human term placenta's fetal membranes are of interest in regenerative medicine due to stem cell and immunomodulatory properties.

Purpose of the Study:

  • To investigate the potential of amniotic membrane in limiting post-ischemic cardiac injury.
  • To assess the functional and morphological effects of amniotic membrane application on ischemic rat hearts.

Main Methods:

  • A fragment of human amniotic membrane was applied to the left ventricle of rats following induced myocardial ischemia (coronary artery ligation).
  • Cardiac function and dimensions were evaluated using echocardiography over a 3-month period.

More Related Videos

Patch Angioplasty in the Rat Aorta or Inferior Vena Cava
06:04

Patch Angioplasty in the Rat Aorta or Inferior Vena Cava

Published on: February 27, 2017

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model
07:03

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model

Published on: March 18, 2019

Related Experiment Videos

Last Updated: Jun 21, 2026

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
06:15

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.

Published on: June 14, 2015

Patch Angioplasty in the Rat Aorta or Inferior Vena Cava
06:04

Patch Angioplasty in the Rat Aorta or Inferior Vena Cava

Published on: February 27, 2017

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model
07:03

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model

Published on: March 18, 2019

Main Results:

  • Ammiotic membrane application significantly reduced post-ischemic cardiac dysfunction.
  • Treated rats exhibited preserved cardiac dimensions and improved ejection fraction, fractional shortening, and wall thickening.
  • Benefits were observed from day 7, persisted for at least 2 months, and were independent of injury severity. No amniotic cell engraftment occurred.

Conclusions:

  • Human amniotic membrane may serve as a vehicle for delivering cardioprotective soluble factors.
  • The amniotic membrane represents a promising cell source for regenerative medicine with unrevealed clinical potential.